OS Therapies
 

New Treatments in Osteosarcoma!

 
img-05.jpg
 
 

Scientific Advisors 

 

Along with our partnership with the Osteosarcoma Collaboration that brings together patients, parents, physicians, advocates and survivors – OS Therapies is proud to have some of the top Osteosarcoma clinicians and physicians on our Scientific Advisory Board. These leaders in research and patient care are on the front-line looking for new ways to defeat an old adversary. Their guidance sets the scientific and clinical direction that will bring new treatments to Osteosarcoma.

 

 

Nabil M. Ahmed, MD - Associate Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine – Texas Children’s Hospital

Peter M. Anderson, MD - Department of Pediatric Hematology, Oncology and Blood & Marrow Transplantation – Cleveland Clinic

Doug S. Hawkins, MD - Professor of Pediatrics, Hematology/Oncology Division - Center for Clinical and Translational Research – Seattle Children’s

Meenakshi Hegde, MD - Assistant Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine – Texas Children’s Hospital

Alejandro Sweet-Cordero, MD - Pediatric Malignancies - Cancer Genetics - Associate Professor of Pediatrics - UCSF

Brenda Weigel, MD – Professor, Division of Pediatric Hematology and Oncology - Masonic Cancer Center – University of Minnesota

Felasfa M. Wodajo, MD - Orthopaedic Surgery - Musculoskeletal Oncology - INOVA Healthcare System  

 
 

Osteosarcoma

Peruvian-Mummy-Tumor.jpg